Heparut Tablet

L-Ornithine L-Aspartate 250 mg + Silymarin 70 mg + Vitamins Tablets

Heparut Tablet — L-Ornithine L-Aspartate 250 mg + Silymarin 70 mg + B-Complex from Trumac Healthcare PCD Pharma Franchise India

Composition L-Ornithine L-Aspartate 250 mg + Silymarin 70 mg + B-Complex
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 1700
Therapy Gastro / Hepatology — Hepatoprotective
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Heparut Tablet

Heparut Tablet combines L-Ornithine L-Aspartate (LOLA) 250 mg with Silymarin 70 mg and B-Complex — a comprehensive hepatoprotective for fatty liver disease, alcoholic liver disease, and prevention/management of hepatic encephalopathy.

LOLA is a clinically validated ammonia-lowering agent — recommended in international guidelines for hepatic encephalopathy. Silymarin adds membrane stabilising and antioxidant action.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Hepatic encephalopathy (prevention/maintenance)
  • Non-alcoholic fatty liver disease (NAFLD)
  • Alcoholic liver disease
  • Hyperammonaemia
  • Drug-induced hepatotoxicity adjunct

Mechanism of Action

L-Ornithine L-Aspartate (LOLA) provides amino acid substrates that drive ammonia detoxification via two complementary pathways — Ornithine fuels the hepatic urea cycle, and Aspartate supports glutamine synthesis in periportal hepatocytes and skeletal muscle. The result is lower blood ammonia and improvement in hepatic encephalopathy. Silymarin (a flavonolignan complex from Silybum marianum) stabilises hepatocyte cell membranes, scavenges free radicals, inhibits Kupffer cell activation, and promotes regenerative protein synthesis in liver cells.

Dosage & Administration

Adults: 1–2 tablets three times daily after meals.

Side Effects

Mild GI upset, nausea, vomiting. Rare hypersensitivity.

Contraindications & Precautions

Severe renal impairment (creatinine > 3 mg/dl), hypersensitivity. Caution in pregnancy.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Heparut Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Heparut Tablet used for?

Heparut Tablet contains L-Ornithine L-Aspartate 250 mg + Silymarin 70 mg + B-Complex. Used as per the indications described above.

How should Heparut Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Heparut Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Heparut Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Heparut Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Heparut Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.